⌘K

Login Start Free

Home/Filings/4/0001933414-25-000013

4//SEC Filing

Karydas Daphne 4

Accession 0001933414-25-000013

CIK 0001933414other

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 6:58 PM ET

Size

5.2 KB

Accession

0001933414-25-000013

Insider Transaction Report

Form 4

Period: 2025-02-13

Mineralys Therapeutics, Inc.MLYS

Director

Transactions

Award
Stock Option
2025-02-13+32,900→ 32,900 total
Exercise: $10.20Exp: 2035-02-13→ Common Stock (32,900 underlying)

Footnotes (1)

[F1]The stock option vests in 12 substantially equal monthly installments following the date of grant.

Documents

1 file

4
wk-form4_1740441514.xmlPrimary
FORM 4

Issuer

Mineralys Therapeutics, Inc.

CIK 0001933414

Entity typeother

Related Parties

1

filerCIK 0001816952

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 6:58 PM ET
Size: 5.2 KB

View on SEC.gov